Poenisch, Wolfram <br/><br/>
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Nov 2015 
 - 2013-22 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-015-1984-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bendamustine Hydrochloride--therapeutic use<br/>Blood Component Removal<br/>Bortezomib--therapeutic use<br/>Disease-Free Survival<br/>Female<br/>Hematopoietic Stem Cell Mobilization--adverse effects<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--therapy<br/>Prednisone--therapeutic use<br/>Retrospective Studies<br/>Transplantation Conditioning<br/>Transplantation, Autologous--adverse effects